Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
about
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Atrial fibrillation: review of current treatment strategiesRate-control or rhythm-control: where do we stand?Management of atrial fibrillationDrug therapy for atrial fibrillationArrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and ManagementManagement Of Atrial Fibrillation In Patients With Heart Failure2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.Atrial Fibrillation: The New Epidemic of the Ageing WorldAtrial fibrillation (acute onset).The rapidly changing management of cardiac arrhythmias.Present concepts in management of atrial fibrillation: From drug therapy to ablation.Ventricular rate control in the elderly: is digoxin enough?Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study.Beta-blocker therapy in atrial fibrillation.Recent advances in drug therapy for atrial fibrillation.Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study.Atrial fibrillation in heart failure: prognostic significance and management.A perspective on rate control in the treatment of atrial fibrillation.Rate control in the medical management of atrial fibrillation.Management of new onset atrial fibrillation in previously well patients less than 60 years of age.Pharmacologic therapies for atrial fibrillation.Management of atrial fibrillation in patients with congestive heart failure.Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.New antiarrhythmic agents for atrial fibrillation and atrial flutter.Antiadrenergic therapy in the control of atrial fibrillation.The safety of digoxin as a pharmacological treatment of atrial fibrillation.Automatically finding relevant citations for clinical guideline development.Rate control in atrial fibrillation, insight into the RACE II studyA practical approach to the management of patients with atrial fibrillation.A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched studyAtrial fibrillation: cure or treat?Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.Rate Control in Atrial Fibrillation: Avoiding Morbidity.Atrial fibrillation: mechanisms, therapeutics, and future directions.Update on the clinical management of atrial fibrillation: guidelines and beyond.Management of postoperative atrial fibrillation.Atrial fibrillation in heart failure: drug therapies for rate and rhythm control.
P2860
Q24800344-357B70EC-04AF-4E91-8F84-D3760115DAADQ27341873-7B472CF7-98DD-435D-BADA-F90A7857B312Q28073181-8886538E-6B29-4325-8041-B9B603150F18Q28200383-3242F48C-0251-4F9D-B1EF-4CA914D2FAEBQ28217428-7C85693F-0632-414D-89A6-1A7292CEAED8Q28218580-FB9F61D0-85BB-41F3-9C81-BBED42307B65Q28268244-6CFF1E00-7A3D-4F80-B4A5-7CD1F8227513Q30354835-3D8C1CA7-E32E-4301-857A-A957577251ADQ30653045-49797A62-388B-40E7-8009-37EC2D8F6F1BQ33168630-43D108A5-01A8-4A66-88FD-C66410FECD73Q33446623-E08DC8EF-3406-4DDE-8531-FE04A686FF05Q33891458-3A8A2DE8-CFCA-40A1-91D5-27A37AAFAC43Q34389483-93089037-59B6-4304-855E-923B0204142DQ34989723-A3E87383-D332-41B8-811B-71CEF65BD257Q35102218-E59AD965-EC22-4D91-9C01-7E2E56F01CE0Q35197755-9D86D79B-A94B-4285-8693-AE4A1F0C62A0Q35209693-7873CF28-F60B-4AC1-8943-15553D5DF034Q35612755-C7790887-B90A-4C4F-8D2E-9C66995A2ADEQ35684055-5D9C0FC9-1756-41EB-99E7-0681B37B24A6Q35720065-C6E34257-2DA4-4692-8B42-8C1C423310FEQ35773042-A3A62181-928C-4480-9CC6-EDC1E9CA2F08Q36022136-2655AF0D-0FBF-43A1-892B-5714F2B4B6AAQ36077766-FE026C9E-7A05-4475-BED4-DF2A3BEA132EQ36077788-F4E6CDCA-404C-4FC5-B951-7CB8DF7329ACQ36108848-9DF78BB9-E376-4A38-B067-BFBB1F86C125Q36150617-0F4910C3-D197-47E4-AD2B-66BA1F91F734Q36167685-47371A10-6E73-4796-9DCD-E8429A78586EQ36446911-4F137D32-A698-4C4D-BB1B-6836AF4A2EF8Q36673851-B6CA7026-B598-43EA-BAF7-2ACBD96A088BQ36905204-68BA9CBD-52C0-4820-9253-41A1E1F8715FQ36982811-37F0A8D9-12FC-4028-B4D9-C86ADE03AFE8Q37305347-AF08DF60-611F-4312-9717-82C6F0A7DD3FQ37483061-E42C1CDD-3BE7-45AE-8B6F-CC8062553B00Q37495803-C077A1E1-113B-4B55-9CAA-7C465BAA4401Q37495894-215704B7-7330-487A-A3A6-3D0D84BD3385Q37496104-1FE53F12-BC11-4BDC-BB6D-B90791484A07Q37590158-1EC48AF9-2B9A-4DFE-A375-91FA98E859ECQ37959147-F80DBCF5-4DD8-4782-84F1-431B8F9F3176Q37978469-8631C60A-657A-46A7-B98C-8D0DD3A7C7F0Q38108265-3D602508-2EA0-4615-892B-0EF04BEB13D4
P2860
Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Ventricular rate control in ch ...... l study of five drug regimens.
@en
Ventricular rate control in ch ...... l study of five drug regimens.
@nl
type
label
Ventricular rate control in ch ...... l study of five drug regimens.
@en
Ventricular rate control in ch ...... l study of five drug regimens.
@nl
prefLabel
Ventricular rate control in ch ...... l study of five drug regimens.
@en
Ventricular rate control in ch ...... l study of five drug regimens.
@nl
P2093
P1476
Ventricular rate control in ch ...... l study of five drug regimens.
@en
P2093
P304
P356
10.1016/S0735-1097(98)00561-0
P407
P577
1999-02-01T00:00:00Z